Kayne Anderson Rudnick Investment Management
NVO

Kayne Anderson Rudnick Investment Management’s Novo Nordisk NVO Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Sell
28,829
-1,291
-4% -$55.5K ﹤0.01% 380
2026
Q1 		$1.11M Buy
30,120
+7,311
+32% +$346K ﹤0.01% 379
2025
Q4 		$1.16M Sell
22,809
-10,964
-32% -$561K ﹤0.01% 371
2025
Q3 		$1.87M Buy
33,773
+10,705
+46% +$627K ﹤0.01% 332
2025
Q2 		$1.59M Sell
23,068
-1,278
-5% -$86.9K ﹤0.01% 341
2025
Q1 		$1.69M Sell
24,346
-1,427
-6% -$118K ﹤0.01% 353
2024
Q4 		$2.22M Sell
25,773
-894
-3% -$96.7K 0.01% 329
2024
Q3 		$3.18M Sell
26,667
-9,941
-27% -$1.33M 0.01% 296
2024
Q2 		$5.23M Sell
36,608
-7,606
-17% -$1.01M 0.01% 281
2024
Q1 		$5.68M Sell
44,214
-7,241
-14% -$862K 0.01% 282
2023
Q4 		$5.32M Buy
51,455
+3,769
+8% +$373K 0.01% 287
2023
Q3 		$4.34M Sell
47,686
-5,148
-10% -$453K 0.01% 296
2023
Q2 		$4.28M Buy
52,834
+2,506
+5% +$205K 0.01% 305
2023
Q1 		$4M Buy
50,328
+9,010
+22% +$639K 0.01% 304
2022
Q4 		$2.8M Buy
41,318
+7,474
+22% +$438K 0.01% 322
2022
Q3 		$1.69M Buy
+33,844
New +$1.81M 0.01% 331
2022
Q2 		– Sell
-90
Closed -$5K – 657
2022
Q1 		$5K Buy
+90
New +$4.62K ﹤0.01% 568
2016
Q3 		– Sell
-127,618
Closed -$3.43M – 338
2016
Q2 		$3.43M Sell
127,618
-2,106
-2% -$57.8K 0.05% 195
2016
Q1 		$3.52M Buy
129,724
+46,906
+57% +$1.26M 0.06% 177
2015
Q4 		$2.4M Buy
82,818
+30,460
+58% +$843K 0.04% 209
2015
Q3 		$1.42M Buy
52,358
+44,950
+607% +$1.27M 0.02% 238
2015
Q2 		$203K Buy
+7,408
New +$208K ﹤0.01% 303

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's NVO Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Novo Nordisk (NVO) stake by 4.3% in Q2 2026, selling an estimated $55.5K and leaving 28,829 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #380.

Kayne Anderson Rudnick Investment Management first reported a position in NVO in Q2 2015 and has held it in 22 quarters since. The position peaked at $5.68M in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 28,829 shares of Novo Nordisk worth $1.38M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 1,291 Novo Nordisk shares in Q2 2026, an estimated $55.5K.
  • Novo Nordisk made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #380 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Novo Nordisk in Q2 2015 and has held it in 22 quarters since.
  • Kayne Anderson Rudnick Investment Management's Novo Nordisk position peaked at $5.68M in Q1 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.